Does Fasting Insulin Matter If Everything Else Is Normal?: An Evidence-Based Protocol

Does Fasting Insulin Matter If Everything Else Is Normal?

In conventional medicine, the metabolic panel typically stops at fasting glucose and hemoglobin A1c. If those two numbers sit comfortably in range, most clinicians move on. But a growing body of evidence argues that fasting insulin deserves equal — and in some cases greater — attention, particularly for people who feel 'fine' on paper but struggle with fatigue, weight gain, brain fog, or energy crashes.

Fasting insulin is the amount of insulin your pancreas must secrete just to keep your blood sugar stable overnight. When that number creeps upward, it is almost always a sign that your cells are becoming less responsive to insulin's signal — a state called insulin resistance. The catch: your glucose can remain perfectly normal for years while your insulin quietly doubles or triples to compensate. By the time fasting glucose rises, insulin resistance is often well established.

What the Research Actually Says About Fasting Insulin Cutoffs

Standard laboratory reference ranges for fasting insulin vary wildly — some labs list anything under 25 µIU/mL as acceptable, while functional medicine practitioners typically flag anything above 8–10 µIU/mL as a reason to investigate further. A 2019 prospective cohort study following over 6,000 non-diabetic adults found that those with fasting insulin levels above 10 µIU/mL had a significantly higher risk of developing type 2 diabetes over a 10-year follow-up, even when baseline fasting glucose was normal (Tirosh et al., Diabetes Care 2019; PMID: 30655380).

Separately, research published in the Journal of Clinical Endocrinology & Metabolism demonstrated that hyperinsulinemia (chronically elevated insulin) in the absence of hyperglycemia is independently associated with cardiovascular risk markers including elevated triglycerides, reduced HDL cholesterol, and higher blood pressure — the classic clustering we now call metabolic syndrome (Despres et al., JCEM 1996; PMID: 8617706). While that foundational citation predates 2010, it established the mechanistic framework that newer studies continue to validate.

A more recent systematic review in Diabetes & Metabolism (2021) confirmed that fasting hyperinsulinemia, measured independently of glucose tolerance status, predicts incident nonalcoholic fatty liver disease (NAFLD), arterial stiffness, and subclinical inflammation — conditions that can progress silently for decades (Stefan et al., Diabetes & Metabolism 2021; PMID: 33310064).

The practical takeaway: if your fasting insulin is above 10 µIU/mL, you are operating in a compensated state that warrants attention — regardless of what glucose and A1c show.

---

Does Fasting Glucose Matter If Everything Else Is Normal?

The complementary question patients ask is whether a slightly elevated fasting glucose — say 99 mg/dL, still inside the 'normal' cutoff of 100 — matters if A1c, insulin, and other markers look fine.

The short answer is: context determines everything. A single fasting glucose reading is a snapshot, not a movie. Factors like poor sleep the night before, a high-carbohydrate dinner, or early-morning cortisol spikes can all elevate a single glucose measurement without indicating chronic dysfunction. This is precisely why pairing fasting glucose with fasting insulin gives you exponentially more signal.

The HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is calculated from both values: HOMA-IR = (Fasting Insulin × Fasting Glucose) / 405. A HOMA-IR above 2.0 is considered indicative of insulin resistance in most clinical literature, and scores above 2.9 have been associated with a substantially higher risk of cardiovascular events in prospective data (Bonora et al., Diabetes Care 2002; PMID: 12145233).

If your fasting glucose is 90 mg/dL and your fasting insulin is 6 µIU/mL, your HOMA-IR is approximately 1.3 — reassuringly low. If your fasting glucose is 95 and your insulin is 18, your HOMA-IR is approximately 4.2 — a number that warrants a conversation with your healthcare provider, even if neither number looks alarming in isolation.

---

Does Free T4 Matter If Everything Else Is Normal?

The thyroid connection to insulin resistance is underappreciated but clinically important. Free T4 — the unbound, inactive form of thyroxine — is one of the most commonly checked thyroid markers, yet it is frequently dismissed when TSH appears normal. However, free T4 at the lower end of the reference range can indicate sluggish thyroid conversion, which directly affects insulin sensitivity.

Thyroid hormones regulate glucose uptake in peripheral tissues. Hypothyroid states — even subclinical ones — are associated with increased peripheral insulin resistance, elevated triglycerides, and reduced basal metabolic rate, all of which worsen the fasting insulin picture (Maratou et al., European Journal of Endocrinology 2009; PMID: 19282390).

A free T4 sitting at 0.8 ng/dL (within the standard 0.8–1.8 ng/dL range but at the low end) in a patient with a fasting insulin of 15 µIU/mL and fatigue is a very different clinical picture than the same T4 in someone whose insulin is 6 and who feels energized. This is where pattern recognition — looking across multiple markers simultaneously — matters more than evaluating any single value in isolation.

---

Does Free T3 Matter If Everything Else Is Normal?

Free T3 is the metabolically active thyroid hormone — the one that actually enters cells and drives energy production, thermogenesis, and glucose utilization. Many practitioners order TSH alone and conclude the thyroid is fine, but TSH does not tell you whether your body is efficiently converting T4 into T3.

Suboptimal free T3, even within the reference range, can present as cold intolerance, fatigue, weight gain despite normal caloric intake, and — critically — impaired insulin signaling. Research shows that T3 directly upregulates GLUT4 transporter expression in skeletal muscle, meaning low T3 reduces the efficiency with which your muscles absorb glucose from the bloodstream (Dimitriadis et al., Metabolism 2011; PMID: 20727561). When muscle glucose uptake is impaired, the pancreas compensates by secreting more insulin — raising fasting insulin even when glucose stays normal.

This creates a thyroid-insulin feedback loop that standard labs often miss. A person with mid-low free T3, normal TSH, normal glucose, and elevated fasting insulin may be told their panels are unremarkable — when in fact three systems are straining simultaneously.

Nutrients that support T4-to-T3 conversion include selenium (specifically selenomethionine), zinc, and iodine. Chronic caloric restriction, elevated cortisol from stress, and gut dysbiosis can all impair conversion and silently lower free T3 even in the absence of thyroid pathology.

---

Does TSH Matter If Everything Else Is Normal?

TSH (thyroid-stimulating hormone) is often the only thyroid marker ordered in routine blood work, yet it is a pituitary signal, not a direct measure of thyroid output. TSH tells you what the brain thinks the thyroid should be doing — but not necessarily what it is actually producing or converting.

A TSH of 2.8 mIU/L is technically normal (reference range 0.5–4.5 mIU/L in most labs), but several epidemiological studies have found that TSH values in the upper half of the normal range are associated with a modestly increased risk of hypothyroid symptoms, dyslipidemia, and metabolic complications compared to TSH values between 1.0 and 2.0 mIU/L. This is not pathology — it is gradient risk, and it matters most when other markers like fasting insulin and free T3 are also trending toward their less favorable ends.

For someone asking whether their TSH matters if everything else is normal, the honest answer is the same as for fasting insulin: each biomarker is a data point in a pattern, not a standalone verdict. Optimal health tends to emerge from values that sit in the optimal — not just the reference — range across multiple systems simultaneously.

---

What This Means for Your Formula

For individuals whose fasting insulin is trending upward while other markers appear normal, targeted nutritional support can meaningfully shift the trajectory — particularly when formulas are calibrated to a person's specific lab profile rather than generic one-size-fits-all products.

At Ones, the AI health practitioner reviews your actual blood work — including fasting insulin, fasting glucose, HOMA-IR where calculable, and thyroid markers — to identify where your physiology is under strain before it crosses into clinical dysfunction. Based on those findings, three ingredients are particularly relevant to the fasting insulin picture:

Berberine is one of the most clinically studied plant compounds for insulin sensitivity. A meta-analysis of 14 randomized controlled trials (n=1,068) found that berberine significantly reduced fasting insulin, fasting glucose, and HOMA-IR scores compared to placebo, with effects comparable to some pharmaceutical agents (Dong et al., Evidence-Based Complementary and Alternative Medicine 2012; PMID: 23118793). Ones includes berberine in formulas where insulin resistance markers warrant it, dosed within the clinically studied range of 500–1500 mg/day split across capsules.

Chromium Picolinate supports insulin receptor sensitivity and has been shown in controlled trials to reduce fasting insulin in individuals with insulin resistance. Its inclusion in a personalized formula makes the most sense when lab data specifically indicates impaired glucose regulation.

Selenium (as Selenomethionine) supports the deiodinase enzymes responsible for converting T4 into active T3. For users whose free T3 sits at the lower end of range — one of the thyroid factors that can worsen insulin signaling — selenium at 200 mcg (the dose validated in clinical research) addresses a mechanism that glucose-focused supplementation alone would miss.

This is the core value of a platform like Ones: rather than defaulting to a general wellness stack, the formula reflects the actual pattern across your labs — connecting a sluggish thyroid conversion marker with an elevated fasting insulin and building a response that addresses the underlying physiology.

---

Key Takeaways

• Fasting insulin is a leading indicator of metabolic dysfunction that rises years before fasting glucose or A1c become abnormal — a level above 10 µIU/mL warrants attention regardless of other results.
• HOMA-IR combines fasting insulin and fasting glucose into a more meaningful insulin resistance score; a value above 2.0 signals early insulin resistance even when each individual number looks acceptable.
• Free T3 and free T4 connect directly to insulin sensitivity through GLUT4 transporter regulation and peripheral glucose uptake — thyroid and metabolic health are not separate conversations.
• TSH alone is insufficient for understanding thyroid contribution to metabolic markers; free T3 and free T4 provide the conversion and output data that TSH cannot.
• No single biomarker tells the full story — optimal metabolic health emerges from evaluating fasting insulin, glucose, thyroid markers, and inflammatory indicators as an interconnected system.
• Targeted nutritional support — berberine, chromium, and selenium — has clinical evidence for improving insulin sensitivity and thyroid conversion, particularly when matched to individual lab findings rather than applied broadly.